Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-10-10

FDA Approved: OXYMORPHONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for oxymorphone hydrochloride from Hikma Pharmaceuticals USA, authorizing a generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxymorphone hydrochloride (Oxymorphone hydrochloride)

Snippet

SUPPL AP for OXYMORPHONE HYDROCHLORIDE (OXYMORPHONE HYDROCHLORIDE)